Abstract:Multiple myeloma (MM) is an incurable B-cell malignancy. High-dose chemotherapy with stem cell support has achieved higher response rates than conventional therapy, but few patients remain in long-term remission. Arsenic trioxide (As2O3) is an effective treatment for acute promyelocytic leukemia. Current clinical studies are investigating arsenic as a therapeutic agent for malignancies. The mechanism of cytotoxicity inducted by As2O3 has not been known thoroughly. Constitutively activated NF-κB is a characteristic of different tumor entities including MM clones and malignant plasma cells from MM patients. It plays an important role in maintaining tumor cell proliferation and protecting cell from apoptosis. The study was to explore the possible mechanism of As2O3 effects on MM lines. Materials and methods: The human MM cell lines of KM3 and RPMI8226 were provided by Hematology Institution of Zhejiang University. The concentration of As2O3 in cell culture system was from 0.5μmol/L to 20μmol/L, 24 hours was selected as the termination point of cell culture. Cell culture without As2O3 and first-antibody-dismissed test were enrolled as controls. Both of the MM lines were treated with As2O3 in various concentrations. The restrained proliferation was observed by drawing growth curve. MTT bioassay was used to examine the effect of As2O3 on cell growth and the concentration of 50% growth inhibition( IC50) calculated respectively. Apoptosis and changes of IκB-α protein was observed by flow cytometry(FCM). Changes and subcellular localization of IκB-α protein were observed by fluorescence microscopy. Western blot was also used to analyze the expression of NF-κB in nuclear. Results: As2O3 inhibited the proliferation of both MM lines, and IC50 of KM3 and RPMI8226 was 9.61μmol/L and 8.01μmol/L respectively. After exposure to As2O3, both of the lines were induced to apoptosis. With As2O3 concentration varied from 0.5μmol/L to 20μmol/L the apoptosis rate of KM3 and RPMI8226 was concentration-dependent measured by FCM. After 24 hours treated with 20μmol/L As2O3, the apoptosis rate of KM3 cells was 41.18% while that of RPMI8226 was 65.25%. It seemed that RPMI8226 cell was more sensitive to As2O3. FCM analysis showed a significant increase in the percentage of G2/M phase cells, from 13.74% to 41.72%, and a decrease percentage of S phase cells from 35.11% to 23.96%. The level of IκB-α in cytoplasm was down-regulated after As2O3 stimulation in both cell lines. The down-regulation of IκB-α from 79.68% to 51.57% was confirmed by FCM in KM3 treated with 10μmol/L As2O3 (p<0.01), the effect was concentration-dependent. While the IκB-α in RPMI8226 changed from 79.72% to 34.08% (p<0.01). Immunofluorescence assay showed that IκB-α localized in cytoplasm mostly. The level of IκB-α protein was down-regulated after As2O3 stimulation. The results showed that KM3 and RPMI8226 lines expressed constitutively activity NF-κB and As2O3 down-regulated the constitutive expression of NF-κB in both cell lines but with different kinetics. Conclusions: As2O3 could not only inhibit the proliferation but also induce apoptosis of KM3 and RPMI8226 cells. The mechanisms of its effect on MM cells may include decreasing the constitutive activity of NF-κB, subsequently down-regulating the expression of various gene products controlled by NF-κB, thus inducing apoptosis in MM cells. As2O3 could inhibit the proliferation of MM cells by changing MM cell cycle and inducing G2/M phase arrest.

[Effect of 2-Methoxyestradiol on Proliferation and Apoptosis of Myeloma Cell Lines].

Effect of 2-Methoxyestradiol on Apoptosis of Bone Marrow Cells of Patients with Multiple Myeloma

[Effect of 2-Methoxyestradiol on Differentiation of Primary Myeloma Cells].

Preliminary investigation of 2-methoxyestradiol inducing differentiation of myeloma cell line CZ-1.

Mechanism Of Arsenic Trioxide-Induced Apoptosis On Multiple Myeloma Cells.

Investigation of the Effect of 2-Methoxyestradiol and Arsenic Trioxide on the Apoptosis-Associated Gene Expression Profile of Myeloma Cells

Mechanisms of 2-Methoxyestradiol-induced Apoptosis on Myelodysplastic Syndrome Mutz-1 Cell Lines.

Effect of 2-methoxyestradiol on cell apoptosis and the expression of bcl-2/bax in SKM-1 cells

Effect of 2-methoxyestradial on the proliferation of bone marrow cells and the changes of c-myc gene expression in multiple myeloma

2-Methoxyestradiol Disrupts Aggresomes Induction by Bortezomib and Potentiates Apoptosis in Multiple Myeloma Cells

[Alterations of Telomerase Activity and Apoptosis Induced by 2-Methoxyestradiol in Human Myelodysplastic Syndrome Cell Line MUTZ-1].

Effects of 2-Methoxyestradiol on Proliferation and Apoptosis of C6 Glioma Cells

Effect of 2-Methoxyestradioi on the Proliferation and Apoptosis of Human Huh7 Cells in Vitro

P38 Mitogen-activated Protein Kinases is Required for Counteraction of 2-Methoxyestradiol to Estradiol-Stimulated Cell Proliferation and Induction of Apoptosis in Ovarian Carcinoma Cells Via Phosphorylation Bcl-2

[Molecular Mechanism of Myeloma Cell Line Differentiation Induced by 2-Methoxyestradiol].

Mechanisms of 2-Methoxyestradiol-induced Apoptosis and G2/M Cell-Cycle Arrest of Nasopharyngeal Carcinoma Cells

HIF-1α inhibition by 2-methoxyestradiol induces cell death via activation of the mitochondrial apoptotic pathway in acute myeloid leukemia

Requirement of reactive oxygen species generation in apoptosis of leukemia cells induced by 2-methoxyestradiol

Radiosensitizing effect of 2-methoxyestradiol on NSCLC cell lines by blocking cell cycle

2-Methoxyestradiol: A Hormonal Metabolite Modulates Stimulated T-Cells Function and proliferation

[Effect of Low-Dose 2-Methoxyestradiol on the Expressions of Two Isoforms of PRDM1 Gene in Myeloma].